Eli Lilly (LLY) intends to expand in China, which, says CEO John Lechleiter, "will soon be the...

|About: Eli Lilly and Company (LLY)|By:, SA News Editor

Eli Lilly (LLY) intends to expand in China, which, says CEO John Lechleiter, "will soon be the second-largest pharmaceutical market in the world." Over 260M Chinese suffer from chronic diseases while healthcare coverage has been expanded to 95% of the population. However, Eli Lilly faces major obstacles, including very slow regulatory approval and poor IP protection.